Cargando…
In vitro and in vivo efficacy of anti‐chikungunya virus monoclonal antibodies produced in wild‐type and glycoengineered Nicotiana benthamiana plants
Chikungunya virus (CHIKV) is a mosquito‐transmitted alphavirus, and its infection can cause long‐term debilitating arthritis in humans. Currently, there are no licensed vaccines or therapeutics for human use to combat CHIKV infections. In this study, we explored the feasibility of using an anti‐CHIK...
Autores principales: | Hurtado, Jonathan, Acharya, Dhiraj, Lai, Huafang, Sun, Haiyan, Kallolimath, Somanath, Steinkellner, Herta, Bai, Fengwei, Chen, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917977/ https://www.ncbi.nlm.nih.gov/pubmed/31207008 http://dx.doi.org/10.1111/pbi.13194 |
Ejemplares similares
-
Expression Profiling and Glycan Engineering of IgG Subclass 1–4 in Nicotiana benthamiana
por: Kallolimath, Somanath, et al.
Publicado: (2020) -
A Monoclonal Antibody Produced in Glycoengineered Plants Potently Neutralizes Monkeypox Virus
por: Esqueda, Adrian, et al.
Publicado: (2023) -
Plant-Produced Anti-Zika Virus Monoclonal Antibody Glycovariant Exhibits Abrogated Antibody-Dependent Enhancement of Infection
por: Yang, Ming, et al.
Publicado: (2023) -
Transient Recombinant Protein Production in Glycoengineered Nicotiana benthamiana Cell Suspension Culture
por: Sukenik, Sara C., et al.
Publicado: (2018) -
Genome and transcriptome characterization of the glycoengineered Nicotiana benthamiana line ΔXT/FT
por: Schiavinato, Matteo, et al.
Publicado: (2019)